Upcoming Eurofins Scientific dividend
Change(%)
0.00%
No change
Next payment N/A
Next payment date N/A
Last payment 1€
Last payment date Jul 6, 2023
00 D 00 H 00 M 00 S
Ex-Dividend: N/A
Not available

Eurofins Scientific has not presented a dividend strategy for 2024.

1 euros per share was the dividend that Eurofins Scientific paid on July 6, 2023.

Eurofins Scientific S.E., listed on the stock exchange of Germany, Austria, United Kingdom and Paris, using the EUFI indicator, has granted this interest to its shareholders since 2007, on an annual basis, every July, maintaining a stable behavior until 2020 when they suspended the payment due to the financial consequences they had because of covid-19, which also generated a decrease in the amount according to the trajectory it was bringing, recovering in 2021 and 2022, it is still waiting for the announcements of the shareholders' meeting regarding the dividend of 2023.

Payout Ratio Eurofins Scientific Dividends

Eurofins Scientific paid 6% of its net income in the last fiscal period as dividends.
Eurofins Scientific's earnings (6,514,599,936.00€) are sufficient to cover the dividend payment. This payment represents 6% of the total net profit of ERF.
Dividend payout ratio
Payout Ratio

Dividend calendar of Eurofins Scientific

There is no Dividend Calendar of Eurofins Scientific defined for 2024.

Historical annual dividend yields of Eurofins Scientific
Over the past 5 years, Eurofins Scientific has not consistently distributed dividends.
Increasing Dividends
Dividend yield
Dividend yield of Eurofins Scientific vs. the sector
Eurofins Scientific's dividend yield (1.90%) is below the sector average (2.50%).
Comparison with industry average
Eurofins Scientific's dividend yield is between the top 25% (4.02%) and top 75% (1.55%) of the sector.
Evaluation with respect to competence.
Dividend yield history in Eurofins Scientific
Over the past 5 years, Eurofins Scientific has not consistently distributed dividends.
Dividend stability

Dividend history of Eurofins Scientific

In this table you can see the complete history:

YearEx-DividendAmountTotal
2023
07/04/2023
1. €
1 €
2022
07/05/2022
1. €
1 €
2021
07/01/2021
0.68 €
0.68 €
2019
07/03/2019
0.288 €
0.288 €
2018
06/28/2018
0.24 €
0.24 €
2017
06/29/2017
0.2 €
0.2 €
2016
06/29/2016
0.145 €
0.145 €
2015
06/29/2015
0.132 €
0.132 €
2014
06/27/2014
0.12 €
0.12 €
2013
07/05/2013
0.1 €
0.1 €
2012
04/03/2012
0.08 €
0.08 €
2011
06/14/2011
0.02 €
0.02 €
2010
09/27/2010
07/08/2010
0.01 €
0.01 €
0.02 €
2009
06/29/2009
0.01 €
0.01 €
2008
07/21/2008
07/10/2008
0.01 €
0.365 €
0.375 €
2007
07/26/2007
0.01 €
0.01 €
Eurofins Scientific dividend capture strategy
Step 1: Buy Eurofins Scientific shares (ERF) one day before ex-dividend date
Date of purchase N/A
Next ex-dividend date N/A
Step 2: Sell Eurofins Scientific shares (ERF) when the price recovers.
Date of sale (estimated) N/A
Average price recovery N/A
Average return on cost N/A
The dividend capture strategy is based on historical Eurofins Scientific data. Past performance is no guarantee of future results.

Information about Eurofins Scientific

Full name Eurofins Scientific SE
Ticker ERF
Sector Health Care
Industry Diagnostics & Research
Market Capitalization 10.11B €
ISIN FR0014000MR3
Number of Employees 62,000
Description of the company

Eurofins Scientific S.E., is a group of laboratories dedicated to perform various tests and services to various industries, mainly pharmaceutical, environmental, food, agricultural sciences, government and consumer products, offering more than 200 thousand types of analysis including clinical diagnostics, in vitro diagnostics, purity, identity and authenticity of biological substances, among others, has about 900 offices, located in 61 countries with headquarters in Luxembourg.

Founded in 1987, in its first ten years it developed and registered the SNIF-NMR patent. In 1997 it began to implement the strategy of purchasing state-of-the-art laboratories with scientific experience and growth potential, expanding initially to eight countries, and in 2001 began to diversify its activities to include genetic markers to verify that the products studied are free of BSE, reaching more than 60 acquisitions.

As a result, it has managed to expand to other countries and continents, such as Canada, the United States, Japan, Taiwan, almost the entire European continent, Asia and America, reaching annual revenues of more than 6.7 million euros, with more than 62,000 employees.

Its services also include consumer testing, biopharmaceutical activities, forensics, genomics, maritime, agro-scientific, cosmetics and personal care, agricultural testing, environmental, food and feed testing, sensory and consumer research, esoteric and molecular diagnostics, among others.

Frequently asked questions about Eurofins Scientific dividends

Eurofins Scientific is listed on the Bourse de Paris and is part of the CAC40.

Eurofins Scientific has the Ticker or stock code ERF.

The CEO of Eurofins Scientific in 2024 is Dr. Gilles G. Martin Ph.D..

Eurofins Scientific ForumCheck the latest comments and participate in the live chat on Eurofins Scientific stocks (ERF).
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments